The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics
Clinical trial NCT02217800 · COMPLETED
Trial details
- NCT number
- NCT02217800
- Sponsor
- Aspireo Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-03-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.